精神分裂症后抑郁患者血浆皮质醇浓度的变化与症状改善的相关性

doi:10.3969/j.issn.2095-9400.2020.02.008

Abstract
Figure/Table
References (0)
Related Citation (4)

Download: PDF (1378 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the relationship between the changes of plasma cortisol levels and the improvement in patients with post schizophrenia depression. Methods: A total of 60 post schizophrenic depression patients from the Affiliated Kangning Hospital of Wenzhou Medical University between March 2018 and December 2018 were enrolled as case group, while 60 cases of schizophrenia after recovery were enrolled as the control group. Both the case group and the control group were only previously treated with risperidone. The plasma cortisol level of the patients was measured by ELISA after entering the group. Paroxetine was added to the case group. Four weeks before and after the treatment, the depressive symptoms of the case group were evaluated by the HAMD scale. After 4-week treatment, the plasma cortisol level of the case group was measured by ELISA. Results: The plasma cortisol level of cases group was significantly higher than that of the control group (t=7.206, P<0.001). After 4 weeks’ treatment, the HAMD total score and factor score of anxiety/somatization, body weight, cognitive disorder, day and night change, retardation, sleep disorder, hopelessness and the plasma cortisol level of the case group were significantly lower than those before treatment (P<0.001). Before and after treatment, the changes of plasma cortisol of the case group were positively related to the improvement of HAMD total scores and factor score of anxiety/somatization, cognitive and hopelessness (r=0.346, 0.367, 0.297, 0.246, P<0.05). The results of linear regression analysis showed the changes of cortisol in the case group could explain 22.5% of the HAMD total, 26.5% of the anxiety/somatization, 17.6% of the cognitive, 13.6% of the hopelessness respectively. Conclusion: The changes of plasma cortisol levels were significantly related to the improvements of symptoms in patients with post schizophrenia depression, so the abnormal plasma cortisol levels might be one of the factors influencing the incidence of post schizophrenia depression.

Key words： post schizophrenic depression depressive disorder plasma cortisol

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Liu Qiaojin
	Wen Na
	Zhu Cheng
	Lu Fanfan

URL:

https://xb.wmu.edu.cn/EN/10.3969/j.issn.2095-9400.2020.02.008 OR https://xb.wmu.edu.cn/EN/Y2020/V50/I2/125

[1] 吴洪军, 张伟娟, 丁跃庆, 等. 精神分裂症患者5年内复发再入院情况分析[J]. 中国健康心理学杂志, 2013, 21(12): 1776-1777.
[2] 闫丽琼, 冯萍, 马良. 精神分裂症患者随访1年的复发规律及因素探讨[J]. 中国健康心理学杂志, 2017, 25(5): 663-666.
[3] 吴祥水, 高镇松, 李植荣. 抗抑郁剂辅助治疗精神分裂症伴焦虑抑郁症状患者对照研究[J]. 临床心身疾病杂志, 2006, 12(4): 258-259.
[4] 李厚勤. 精神分裂症的继发性抑郁[J]. 国外医学(精神病学分册), 1987,14(2): 84-87.
[5] HAMILTON M. Development of a rating scale for primary depressive illness[J]. Br J Soc Clin Psychol, 1967, 6(4): 278-296.
[6] BABINKOSTOVA Z, STEFANOVSKI B, JANICEVIC-IVANOVSKA D, et al. Serum cortisol and DHEA-S levels in schizophrenic patients with different response to antipsychotic therapy: association with psychopathology[J]. Pril (Makedon Akad Nauk Umet Odd Med Nauki), 2015, 36(1): 175-182.
[7] MONTELEONE P, DI FILIPPO C, FABRAZZO M, et al. Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure[J]. Psychiatry Res, 2014, 215(2): 263-267.
[8] 金卫东, 藏德馨. 14例I型精神分裂症患者下丘脑-垂体-肾上腺功能与症状学的关系[J]. 湖北医学院学报, 1990, 11(3): 248-250.
[9] 高晓峰, 何鲜艳, 兰智勇, 等. 血浆5-羟色胺和皮质醇水平与抑郁患者病情严重程度的相关性[J]. 中国慢性病预防与控制, 2017, 25(2): 129-130.
[10] 李欣, 薛坤喜, 万静, 等. 伴抑郁症状的首发精神分裂症患者血清皮质醇水平的相关研究[J]. 数理医药学杂志, 2016, 29(7): 1019-1019, 1020.
[11] 张深山. 精神分裂症患者的焦虑抑郁症状与血浆皮质醇水平观察[J]. 四川精神卫生, 2009, 22(4): 196-198.
[12] 齐小强. 精神分裂症抑郁[J]. 国外医学(精神病学分册), 2002, 29(1): 15-17.
[13] 傅强, 赵鹏, 喻东山. 抑郁症患者血清皮质醇水平分析[J]. 中国实用医药, 2007, 2(33): 20-22.
[14] 刘芙蓉, 周平, 刘联琦, 等. 伴有抑郁症状的精神分裂症患者的血清皮质醇及甲状腺功能特征[J]. 四川精神卫生, 2015, 28(3): 224-226, 227.
[15] 蒋昕, 纪家武, 陈红岩, 等. 精神分裂症下丘脑-垂体-肾上腺轴功能研究[J]. 临床精神医学杂志, 2008, 18(5): 292-294.
[16] 李宏伟, 高镇松, 郭赛玲, 等. 精神分裂症患者HPA轴释放功能与自杀行为相关性研究[J]. 精神医学杂志, 2015, 28(3): 175-178.
[17] 李宏伟, 高镇松, 吴强, 等. 抑郁障碍患者丘脑-垂体-肾上腺轴释放功能与病情关系的研究[J]. 黑龙江医学, 2011, 35(11): 808-810, 855.
[18] 陈淑玲, 倪明慧, 徐乐平. 褪黑素水平对抑郁症患者下丘脑-垂体-肾上腺轴功能的影响[J]. 中国健康心理学杂志, 2014, 22(9): 1293-1295, 1296.
[19] 张小红, 盛江明, 黄迟, 等. 唾液皮质醇与围引产期抑郁的相关性[J]. 中南大学学报(医学版), 2019, 44(9): 1023-1029.